D.E. Shaw & Co
BHVN icon

D.E. Shaw & Co’s Biohaven BHVN Stock Holding History

D.E. Shaw & Co’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,100
Closed -$509K – 4557
2025
Q4 		$509K Buy
+45,100
New +$559K ﹤0.01% 3923

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's BHVN Position: Q1 2026 in Review

D.E. Shaw & Co increased its Biohaven (BHVN) stake by 5.7% in Q1 2026, buying an estimated $1.67M and bringing the position to 2,847,193 shares worth $24.1M. The position accounts for 0.01% of the portfolio, ranked #1032.

D.E. Shaw & Co first reported a position in BHVN in Q4 2022 and has held it in 12 quarters since. The position peaked at $30.4M in Q4 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • D.E. Shaw & Co held 2,847,193 shares of Biohaven worth $24.1M as of Q1 2026.
  • D.E. Shaw & Co bought 152,959 Biohaven shares in Q1 2026, an estimated $1.67M.
  • Biohaven made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1032 holding.
  • D.E. Shaw & Co first reported a position in Biohaven in Q4 2022 and has held it in 12 quarters since.
  • D.E. Shaw & Co's Biohaven position peaked at $30.4M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.